Shanjun Wu
Impact in
- Ophthalmology top 2%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Retinal and Optic Conditions
- Ocular Infections and Treatments
- Health Informatics top 5%
Papers in
-
- Glaucoma and retinal disorders 7
- Retinal and Optic Conditions 5
- Retinal Diseases and Treatments 5
- Intraocular Surgery and Lenses 3
- Ocular Diseases and Behçet’s Syndrome 2
-
- Retinal Imaging and Analysis 8
- Corneal surgery and disorders 3
- Co-authors
- Jiewei JiangXiaotian LiuQinxiang ZhengKuan ChenYuewen WangPengyun WangZhongwen LiLingyun Cheng
- Journals
- Current Eye Research (2 papers)iScience (1 paper)Scientific Reports (1 paper)Medicine (1 paper)Frontiers in Cell and Developmental Biology (1 paper)
- Partner nations
- ChinaUnited StatesNigeria
In The Last Decade
Shanjun Wu
16 papers receiving 345 citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Ophthalmology 221
- Health Informatics 25
- Radiology, Nuclear Medicine and Imaging 225
- Epidemiology 61
- Health Information Management 8
Countries citing papers authored by Shanjun Wu
This map shows the geographic impact of Shanjun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanjun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanjun Wu more than expected).
Fields of papers citing papers by Shanjun Wu
This network shows the impact of papers produced by Shanjun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanjun Wu. The network helps show where Shanjun Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shanjun Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 9 | |
| 5 | Artificial intelligence in ophthalmology: The path to the real-world clinic Hit paper breakdown → | 2023 | 78 |
| 6 | 2022 | 1 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 6 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 14 | |
| 13 | 2021 | 84 | |
| 14 | 2021 | 1 | |
| 15 | 2020 | 22 | |
| 16 | 2019 | 68 | |
| 17 | 2018 | 4 | |
| 18 | Metformin inhibits development of diabetic retinopathy through inducing alternative splicing of VEGF-A. | 2016 | 45 |
About Shanjun Wu
Shanjun Wu is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Biological Psychiatry, Hepatology and Neurology, having authored 18 papers that have together received 350 indexed citations. Recurring topics across this work include Retinal Imaging and Analysis (8 papers), Glaucoma and retinal disorders (7 papers), Retinal and Optic Conditions (5 papers), Retinal Diseases and Treatments (5 papers), Corneal surgery and disorders (3 papers), Intraocular Surgery and Lenses (3 papers), Angiogenesis and VEGF in Cancer (2 papers) and Ocular Diseases and Behçet’s Syndrome (2 papers). The work is most often cited by research in Ophthalmology (221 citations), Health Informatics (25 citations), Radiology, Nuclear Medicine and Imaging (225 citations), Epidemiology (61 citations) and Health Information Management (8 citations). Shanjun Wu has collaborated with scholars based in China, United States and Nigeria. Frequent co-authors include Jiewei Jiang, Xiaotian Liu, Qinxiang Zheng, Kuan Chen, Yuewen Wang, Pengyun Wang, Zhongwen Li, Lingyun Cheng, Qianqian Chen and Zhongwen Li. Their work appears in journals such as Current Eye Research, iScience, Scientific Reports, Medicine and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.